Ladenburg Thalmann Financial Services’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
DCP
Ladenburg Thalmann Financial Services's NVCR Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services reduced its NovoCure (NVCR) stake by 6.8% in Q4 2019, selling an estimated $30.8K and leaving 5,195 shares worth $425K. The position accounts for ﹤0.01% of the portfolio, ranked #1946.
Ladenburg Thalmann Financial Services first reported a position in NVCR in Q4 2015 and has held it in 17 quarters since. 262 funds tracked by Wall St. Rank hold NVCR as of Q4 2019.
- Ladenburg Thalmann Financial Services held 5,195 shares of NovoCure worth $425K as of Q4 2019.
- Ladenburg Thalmann Financial Services sold 382 NovoCure shares in Q4 2019, an estimated $30.8K.
- NovoCure made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1946 holding.
- Ladenburg Thalmann Financial Services first reported a position in NovoCure in Q4 2015 and has held it in 17 quarters since.
- 262 funds tracked by Wall St. Rank held NovoCure as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.